InnovationOct 12, 2026PhD Competition Highlights Emerging Research in Drug Discovery and DevelopmentThree PhD researchers recognised at FIGON-LDDC Dutch Medicines Days 2026 for their work on vascular health, brain ageing and cell therapy safety
InnovationOct 12, 2026PhD Competition Highlights Emerging Research in Drug Discovery and DevelopmentThree PhD researchers recognised at FIGON-LDDC Dutch Medicines Days 2026 for their work on vascular health, brain ageing and cell therapy safety
InnovationOct 12, 2026PhD Competition Highlights Emerging Research in Drug Discovery and DevelopmentThree PhD researchers recognised at FIGON-LDDC Dutch Medicines Days 2026 for their work on vascular health, brain ageing and cell therapy safety
Innovation Remynd secures €3.5 million investment from the Alzheimer's Drug Discovery Foundation to take its first-in-class septin modulator into Alzheimer's patients
Innovation Remynd secures €3.5 million investment from the Alzheimer's Drug Discovery Foundation to take its first-in-class septin modulator into Alzheimer's patients
Innovation Remynd secures €3.5 million investment from the Alzheimer's Drug Discovery Foundation to take its first-in-class septin modulator into Alzheimer's patients
InnovationLeyden Labs Reports Positive Phase 1 Results for RIG-101, Supporting Advancement into Phase 2 to Protect Asthma Patients
InnovationLeyden Labs Reports Positive Phase 1 Results for RIG-101, Supporting Advancement into Phase 2 to Protect Asthma Patients
InnovationLeyden Labs Reports Positive Phase 1 Results for RIG-101, Supporting Advancement into Phase 2 to Protect Asthma Patients
InnovationCleara Biotech Secures U.S. and Chinese Patent Protection for its p53-Targeting Development Candidate CL04183
InnovationCleara Biotech Secures U.S. and Chinese Patent Protection for its p53-Targeting Development Candidate CL04183
InnovationCleara Biotech Secures U.S. and Chinese Patent Protection for its p53-Targeting Development Candidate CL04183
IndustryFrom targeted quantification to in-depth characterization: Anabiotec expands its mass spectrometry capabilities
IndustryFrom targeted quantification to in-depth characterization: Anabiotec expands its mass spectrometry capabilities
OpinionCFO in Life Sciences: The Difference Between Financial Administration and Financial Leadership
OpinionCFO in Life Sciences: The Difference Between Financial Administration and Financial Leadership
IndustryFrom targeted quantification to in-depth characterization: Anabiotec expands its mass spectrometry capabilities
OpinionCFO in Life Sciences: The Difference Between Financial Administration and Financial Leadership
